BTW for anyone who wants to help but thinks this is mostly wetlab/drug development work. There's quite a bit of room in the space for the computer-vision side of things to improve decision-making and time to treat. I think it's mostly based on phenotyping by imaging and identifying low-specimen cultures but I might be totally wrong.
I am trying for nearly a year to get a grant for my multi-objective drug combinations therapy optimizer, which seeks to adapt drug combination regimens for long-term robustness against emerging drug resistance. And I am getting one rejection after another.
I mean, yes, there is a crisis. We need action now. Many people are offering solutions and new research directions. But money are simply not there.
I mean, yes, there is a crisis. We need action now. Many people are offering solutions and new research directions. But money are simply not there.